Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.96p
   
  • Change Today:
      0.41p
  • 52 Week High: 13.00p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 2,160,370
  • Market Cap: £20.64m
  • Beta: 0.01

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
02-Jan-25 Shore Capital House Stock 4.27p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 2.96p
Change Today 0.41p
% Change 16.08 %
52 Week High 13.00p
52 Week Low 2.40p
Volume 2,160,370
Shares Issued 697.20m
Market Cap £20.64m
Beta 0.01

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.41% below the market average48.41% below the market average48.41% below the market average48.41% below the market average48.41% below the market average
2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average
Price Trend
91.05% below the market average91.05% below the market average91.05% below the market average91.05% below the market average91.05% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 11-Aug-2025

Time Volume / Share Price
15:40 125,000 @ 2.86p
15:21 4,265 @ 2.86p
14:38 123,005 @ 2.86p
14:37 41,195 @ 2.86p
14:26 82,368 @ 2.86p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page